According to the degree of restriction, in hepatic impairment the most plasma focus of nortilidine is decreased than in hepatic healthy subjects as well as 50 percent-lifetime is extended. In cases of severe hepatic impairment, therapy is questionable. Use or redistribution of any DrugBank content or information requires a license https://hilairec260mwy1.bloggerchest.com/profile